2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Breast
1
Conditions
Solid Tumors
1
Interventions
Paclitaxel
15
atezolizumab
11
Gemcitabine
11
Carboplatin
9
pembrolizumab
8
Docetaxel
8
Bevacizumab
8
Irinotecan
7
Injections
6
Cetuximab
6
Capecitabine
6
Sunitinib
5
Leucovorin
5
Fluorouracil
5
Cyclophosphamide
5
tocilizumab
4
pazopanib
4
olaparib
4
navitoclax
4
liposomal doxorubicin
4
Topotecan
4
Oxaliplatin
4
Nivolumab
4
Erlotinib Hydrochloride
4
temsirolimus
3
spartalizumab
3
lenvatinib
3
fludarabine
3
cobimetinib
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solid Tumors
×
somatostatin receptor 2
×
Clear all
NCT07178938
2025-11-14
THERANOVA
MedSIR
Phase 2
Not yet recruiting
10 enrolled